FNUSA-ICRC Supervisory Board (FNUSA-ICRC SB)

The Supervisory Board is the highest supervisory body of FNUSA-ICRC. It supervises all FNUSA-ICRC activities particularly in the fields of research and development, technology transfer, education, human resources, economy, and legal and ethical issues.

Ing. Vlastimil Vajdák

Ing. Vlastimil Vajdák

Vlastimil Vajdák graduated from the Faculty of Management and Economics in Zlín and gained experience in ČSOB as Regional Director. He worked in the management of Hospital in Uherské Hradiště as a member of the Board of Directors and Economic Deputy. Since 2017 he has been a member of the Board of Directors of the Tomáš Baťa Regional Hospital in Zlín, where he was in charge of the economic and operational-business area. He is the director of St. Anne’s University Hospital in Brno and Chairman of the Supervisory Board of FNUSA-ICRC.

Prof. MUDr. Marek Svoboda, Ph.D.

Prof. MUDr. Marek Svoboda, Ph.D.

Prof. MUDr. Marek Svoboda, Ph.D. graduated from the Faculty of Medicine of Masaryk University in Brno. He specializes in clinical oncology and cancer research. Since 2019 he has been the director of the Masaryk Memorial Cancer Institute in Brno.

Prof. Dr. Dr. habil. Thomas Braun

Prof. Dr. Dr. habil. Thomas Braun

Prof. Dr. Habil. Thomas Braun, Director and Scientific Member at the Max Planck Institute for Heart and Lung Research He studied philosophy and medicine in Göttingen and Hamburg, PhD in Medicine (1987), German Habilitation in biochemistry (1993), University of Hamburg, Professor at the University Halle-Wittenberg, Director of the Institute of Physiological Chemistry (1998-2004).

Vaughn E. Ostland, Ph.D.

Vaughn E. Ostland, Ph.D.

Vaughn Ostland PhD is Vice President and Chief Operations Officer of Intrinsic LifeSciences LLC. He is a founding member and is responsible for a wide range of management, R&D and manufacturing duties, including Information Technology infrastructure, maintaining regulatory compliance and managing Intrinsic LifeSciences LLC’s patent portfolio.

MUDr. Jakub Tolar, Ph.D.

MUDr. Jakub Tolar, Ph.D.

Jakub Tolar is a dean of the University of Minnesota Medical School and a Professor in the Department of Pediatrics, Blood and Marrow Transplantation. Jakub Tolar received his medical education in Prague at the Charles University. In 1992, he came to the University of Minnesota, where he completed his Ph.D. in Molecular, Cellular & Developmental Biology and Genetics. Since 2011, Jakub Tolar is a director of the Stem Cell Institute of the University of Minnesota.

Ing. Pavel Trcka

Ing. Pavel Trcka

Pavel Trcka is an independent consultant in corporate finance. He graduated from the School of Economics, Bratislava, in International trade and International finance. His banking career started in 1990 in Citibank a.s. Prague in the position of head of the consulting department for international investors in Czechoslovakia, later as a senior relationship manager for international companies. Between 1993 and 2009 he worked in Raiffeisenbank a.s. specializing in the financing of companies and foreign trade.

Prof. Robert Zorec, B.Sc., M.Sc., Ph.D.

Prof. Robert Zorec, B.Sc., M.Sc., Ph.D.

Robert Zorec is Professor of Pathophysiology at the University of Ljubljana, Medical Faculty. He is a Member of Slovenian Academy of Sciences and Arts and Academia Europaea. Dr. Zorec received his Ph.D. from the University of Ljubljana in 1986 for his work conducted at the Newcastle Medical School. Dr. Zorec postdoctoral experience was at Cambridge in Dr. W. T. Mason´s laboratory. Since 1991 he has been the Head of Laboratory of Neuroendocrinology-Molecular Cell Physiology. In 1997 he received the Republic of Slovenia Prize for Science. In 2000 he established the Cell Engineering Laboratory BIOMEDICAL, Ljubljana where he has been a CEO since 2006.

Ing. Miroslav Zámečník

Ing. Miroslav Zámečník

Miroslav Zamecnik is a Czech economist and publicist specializing in financing and economics of healthcare systems. He graduated from the University of Economics in Prague and participated in the Pew Fellow Program of Georgetown University (Washington, D.C.). In the early 1990s he was the Director of Center for Economic Analyses in the office of President Vaclav Havel. During 1994-1998 he was the Czech representative at the World Bank, in 1998-1999 he worked at Arthur D. Little as a Senior Consultant for the Czech Ministry of Finance. During 2000-2001 he worked as the Deputy-Director of the government company restructuring body Revitalisation Agency and the Deputy-Director of the government-owned Consolidation Bank.

Prof. Martin Pichler

Prof. Martin Pichler

Professor Martin Pichler, MD, MSc, received his MD at the Medical University of Graz, and his Master degree in Molecular Biology at the Karl-Franzens University Graz, Austria. Dr. Pichler continued his cancer research training at the Medical University of Graz, Austria and at the University of Texas MD Anderson Cancer Center in Houston, USA. Now he works at the Medical university of Graz, Austria, Division of Oncology.

Prof. Beata Mladosievicova, MD, Ph.D.

Prof. Beata Mladosievicova, MD, Ph.D.

Prof. Beata Mladosievicova, MD, Ph.D. graduated from the Faculty of Medicine of Comenius University in Bratislava, with which her professional career is connected. He currently works at the Department of Clinical Pathophysiology, Faculty of Medicine, Comenius University in Bratislava.

Mgr. Michal Matula

Mgr. Michal Matula

Mgr. Michal Matula studied molecular biology and genetics at Masaryk University in Brno, after graduating he founded the company Internet Billboard, where he still works as CEO and chairman of the board.